Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte CorpfiledCriticalIncyte Corp
Publication of AR117459A1publicationCriticalpatent/AR117459A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Se describen compuestos de fórmula (1), métodos para usar los compuestos para inhibir la actividad de ALK2 y composiciones farmacéuticas que comprenden tales compuestos. Los compuestos son útiles para tratar, prevenir o mejorar enfermedades o trastornos asociados con la actividad de ALK2, como el cáncer.Compounds of formula (1), methods for using the compounds to inhibit ALK2 activity, and pharmaceutical compositions comprising such compounds are described. The compounds are useful for treating, preventing, or ameliorating diseases or disorders associated with ALK2 activity, such as cancer.
ARP190103782A2018-12-202019-12-19
IMIDAZOPYRIDINE AND IMIDAZOPYRIDAZINE COMPOUNDS AND USES OF THEM
AR117459A1
(en)